News / Health

Anti-AIDS Drug Reduces Risk of HIV Transmission

Multimedia

A daily dose of an antiretroviral drug used to treat AIDS patients reduced the risk of HIV transmission by nearly 44 percent in a large international study of uninfected homosexual men and transgender men who have sex with men. Scientists say that although the results are very encouraging, more studies are needed to confirm the findings among other high risk populations.

The Chemoprophylaxis for HIV Prevention in Men, or iPrEX study, recruited 2,500 HIV negative or uninfected men in Brazil, Ecuador, Peru, South Africa, Thailand and the United States in 2007 to receive the antiretroviral drug Truvada or a placebo.

Truvada is a compound made up of two widely available generic AIDS drugs - tenofavir and emtricitabine.

At the end of the 14 month study, 100 men had acquired HIV. But there were 43.8 percent fewer infections among men in the treatment group than in the group that received the sugar pill.

Watch Melinda Smith's Companion TV Report:

More striking, researchers say, was a 73 percent lower risk of infection among men who adhered most closely to the daily drug regimen.

"The bottom line is that this is a very significant finding in the quest toward developing more comprehensive ways of preventing HIV infection," said Anthony Fauci, director of the Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health, which sponsored the study led by researchers at the University of California, San Francisco.

Dr. Fauci says more studies will be conducted to learn whether the drug works just as well to prevent HIV transmission among other high-risk individuals, including heterosexuals, in countries where infection with the AIDS virus has reached near-epidemic proportions.

"Men who have sex with men, as we know, are at the higher level of risk among people who acquire HIV infection.  And so if it works in these individuals, it is very likely we will see similar results in women as well as heterosexual men," he said.

"The results are very encouraging.  And this study really represents a major advance in HIV prevention research," said Kevin Fenton, Director of the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention at the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia.

But Dr. Fenton cautions that daily doses of Truvada, which cost between $5,000 and $7,000 per year in the United States, are unlikely to be widely available in the developing world -- at least, not right away.

He says he expects researchers will begin exploring the effectiveness of using less expensive antiretroviral drugs to protect high risk individuals.

Dr. Fenton says that any drug therapy, known as preexposure chemoprophylaxis, or PrEP, will need to be combined with other well-established prevention strategies to lower the risk of HIV transmission. "The reality is that PrEP is not going to be right for everyone.  It's not 100 percent effective.  And when it is used, it will have to be used in partnership with very comprehensive monitoring, support and prevention services," he said.

Dr. Fenton says such services include regular testing for other sexually-transmitted diseases that put individuals at higher risk for HIV infection, and education about risky lifestyle behaviors, such as drug abuse and unsafe sexual practices.

An article detailing the findings of the Chemoprophylaxis for HIV Prevention in Men study is published in The New England Journal of Medicine.

You May Like

EU Court Fines Poland for Hosting CIA 'Black Sites'

Ruling is first time a court has acknowledged suspects were held and tortured at the sites, under US program launched following the 9/11 terrorist attacks More

Migrant Issues Close to Home Spur Groups to Take Action

Groups placing water, food in the desert, or aiding detainees after release, have one common goal: no more deaths of migrants crossing illegally into the US More

Video At AIDS Conference, Prevention Pill Stirs Excitement

Truveda shows promise, spurring debate over access and other approaches More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Treatment for Childhood Epilepsy Heats up Medical Marijuana Debatei
X
Shelley Schlender
July 24, 2014 6:43 PM
In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Treatment for Childhood Epilepsy Heats up Medical Marijuana Debate

In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Airbus Adds Metal 3D Printed Parts to New Jets

By the end of this year, European aircraft manufacturing consortium Airbus plans to deliver the first of its new, extra-wide-body passenger jets, the A350-XWB. Among other technological innovations, the new plane will also incorporate metal parts made in a 3-D printer. VOA's George Putic has more.
Video

Video Death Toll From Israel-Gaza Conflict Surpasses 700

Gaza officials say a shelling hit a compound housing a United Nations-run school in the Gaza Strip, killing more than a dozen people, during an Israeli offensive in the area. Heavy fighting between the Israeli military and Hamas militants continued on Thursday, pushing up the death toll. So far, more than 730 Palestinians and 35 Israelis have been killed in the conflict. VOA's Scott Bobb has the latest from Jerusalem.
Video

Video AIDS Conference Welcomes Exciting Developments in HIV Treatment, Prevention

Significant strides have been made in recent years toward the treatment and prevention of HIV, the virus that causes AIDS. This year, at the International AIDS Conference, the AIDS community welcomed progress on a new pill that may prevent transmission of the deadly virus. VOA’s Anita Powell reports from Melbourne, Australia.
Video

Video Israel Targets Gaza Supply Tunnels

The Israeli military has launched a ground operation in Gaza to destroy the myriad tunnels that may have been used to smuggle weapons to Hamas. VOA's Zlatica Hoke reports that could mean more hardship for the people of Gaza, who obtain some of their essential supplies through these underground passages
Video

Video Researchers Target Low-Cost Avatar Technology

Scientists at the University of Southern California Institute for Creative Technologies say 3-dimensional representations could revolutionize social media. Elizabeth Lee has more from Los Angeles.
Video

Video IAEA: Iran Turns its Enriched Uranium Into Less Harmful Form

Iran has converted its stockpiles of enriched uranium into a less dangerous form that is more difficult to use for nuclear weapons, according to the United Nations’ Atomic Energy Agency. The move complies with an interim deal reached with Western powers on Iran's nuclear program last year, in exchange for easing of sanctions. Henry Ridgwell reports for VOA from London.
Video

Video In Cambodia, HIV Diagnosis Brings Deadly Shame

Although HIV/AIDS is now a treatable condition, a positive diagnosis is still a life altering experience. In Cambodia, people living with HIV are often disowned by friends, family and the community. This humiliation can be unbearable. We bring you one Cambodian woman’s struggle to overcome a life tragedy and her own HIV positive diagnosis.

AppleAndroid